Navigation Links
Growth-factor-containing nanoparticles accelerate healing of chronic wounds
Date:1/26/2011

Massachusetts General Hospital (MGH) investigators have developed a novel system for delivery of growth factors to chronic wounds such as pressure sores and diabetic foot ulcers. In their work published in the Jan. 18 Proceedings of the National Academy of Sciences, the team from the MGH Center for Engineering in Medicine (CEM) reports fabricating nanospheres containing keratinocyte growth factor (KGF), a protein known to play an important role in wound healing, fused with elastin-like peptides. When suspended in a fibrin gel, these nanoparticles improved the healing of deep skin wounds in diabetic mice.

"It is quite amazing how just one dose of the fusion protein was enough to induce significant tissue regeneration in two weeks" says the paper's lead author Piyush Koria, PhD, formerly a postdoctoral fellow at the MGH-CEM and now at the University of South Florida. "Previous reports have suggested that KGF can help heal chronic wounds. But in most studies the growth factor was applied to the surface of the wound, limiting its availability to deeper tissues and requiring repeat applications to produce any clinical benefit. Using large quantities of growth factor would make this therapy extremely expensive. Our work circumvents these limitations by more efficiently delivering KFG throughout the wound to stimulate tissue regeneration."

The authors describe developing a fusion protein from recombinant KGF and elastin-like-peptides, which are major constituents of skin and other connective tissues. Laboratory experiments showed that the fusion protein retained the wound-healing properties of both elastin and KGF and that it rapidly and efficiently self-assembled into nanoparticles in response to a simple increase in temperature. When applied to deep skin wounds in genetically diabetic mice, the nanoparticles accelerated healing by stimulating the formation of both surface epithelial tissue and thick fibrous connective tissue.

"This technology has great potential because the fusion protein can be easily manufactured at a relatively low cost, is easy to administer and does not disappear as readily as the growth factor alone," explains Martin Yarmush, MD, PhD, director of the MGH Center for Engineering in Medicine and senior author of the study. "The technology also provides a platform for delivery of any growth factor or combination of factors. One could imagine administering a mixture of nanoparticles, each with a different factor, or a single set of nanoparticles with a mixture of fusion proteins on each."


'/>"/>

Contact: Sue McGreevey
smcgreevey@partners.org
617-724-2764
Massachusetts General Hospital
Source:Eurekalert

Related biology news :

1. With chemical modification, stable RNA nanoparticles go 3-D
2. Cinnamon can replace harmful chemicals used to create nanoparticles
3. Drugs encased in nanoparticles travel to tumors on the surface of immune-system cells
4. Probing the nanoparticle: Predicting how nanoparticles will react in the human body
5. How many nanoparticles heat the tumor?
6. NIST nanofluidic multi-tool separates and sizes nanoparticles
7. New catalyst of platinum nanoparticles could lead to conk-out free, stable fuel cells
8. Nanoblasts from laser-activated nanoparticles move molecules, proteins and DNA into cells
9. Researchers use nanoparticles as destructive beacons to zap tumors
10. K-State researchers find gene-silencing nanoparticles may put end to pesky summer pest
11. Researchers use nanoparticles to shrink tumors in mice
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/11/2017)... NXT-ID, Inc. (NASDAQ:   NXTD ) ("NXT-ID" or ... independent Directors Mr. Robin D. Richards and Mr. ... the company,s corporate governance and expertise. ... Gino Pereira , Chief Executive Officer said," ... and benefiting from their considerable expertise as we move forward ...
(Date:4/4/2017)... NEW YORK , April 4, 2017   ... solutions, today announced that the United States Patent and ... The patent broadly covers the linking of an iris ... the same transaction) and represents the company,s 45 th ... our latest patent is very timely given the multi-modal ...
(Date:3/29/2017)... , March 29, 2017  higi, the health ... in North America , today announced ... and the acquisition of EveryMove. The new investment and ... set of tools to transform population health activities through ... lifestyle data. higi collects and secures data ...
Breaking Biology News(10 mins):
(Date:8/10/2017)... ... August 09, 2017 , ... As a ... reach its ideal customers with the right message. Their effective, cutting-edge inbound marketing ... company, we realize how crucial the agriculture industry is,” said David Phelps, chief ...
(Date:8/10/2017)... ... August 09, 2017 , ... Each year in the United States more than ... live an independent lifestyle and, even worse, the one-year mortality rate is high, ranging ... the University of California Davis Medical Center (Sacramento) and Second Xiangya Hospital of the ...
(Date:8/10/2017)... ... August 10, 2017 , ... DrugDev and the Society ... to demonstrate how Good Clinical Practice (GCP) can be used throughout the site activation ... will discuss the importance of GCP compliance, how sites are affected by GCP during ...
(Date:8/10/2017)... , ... August 10, 2017 , ... ... the AptaFluor SAH Methyltransferase Assay , an enabling new high throughput screening ... pathways that drive cancer and other debilitating diseases. , Chemical modification of gene ...
Breaking Biology Technology: